Research map: An updated overview of alkaloids for the prevention and treatment of metabolic dysfunction-associated steatotic liver disease

Back to the article

Papers in this map

  1. Global burden of liver disease: 2023 update · Harshad C. Devarbhavi · 2023 · 2217 citations · Cited by this paper
  2. Tislelizumab combined with Anti-GD2 antibody-based chemoimmunotherapy for pediatric relapsed/refractory high-risk neuroblastoma: a two-Case Report · 2026 · Related
  3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) · Frank Tacke · 2024 · 2049 citations · Cited by this paper
  4. Linalool in cancer pharmacology: pharmacokinetic limitations and preclinical cytotoxic evidence for translational development · 2026 · Related
  5. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial · Melanie J. Davies · 2021 · 1389 citations · Cited by this paper
  6. A nomogram based on LASSO-logistic regression for predicting tocilizumab-associated hypofibrinogenemia in patients with rheumatic diseases · 2026 · Related
  7. Energy-stress-mediated AMPK activation inhibits ferroptosis · Hyemin Lee · 2020 · 1159 citations · Cited by this paper
  8. Traditional Chinese medicine interventions targeting Wnt/β-catenin signaling in cerebral ischemia/reperfusion injury: a review · 2026 · Related
  9. Emerging connectivity of programmed cell death pathways and its physiological implications · Sammy Bedoui · 2020 · 996 citations · Cited by this paper
  10. NSFC-funded Chinese materia medica research (2015–2024): achievements output, research characteristics, and evolution · 2026 · Related
  11. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes · Domenica M. Rubino · 2022 · 938 citations · Cited by this paper
  12. Endothelial EPAS1 as a prognostic and therapeutic target in acute myocardial infarction: integrative bioinformatics, Mendelian randomization and experimental validation · 2026 · Related
  13. Gut-liver axis: Pathophysiological concepts and clinical implications · Herbert Tilg · 2022 · 827 citations · Cited by this paper
  14. Liver and kidney cross talk: liver-derived bile acids and kidney water retention · 2026 · Related
  15. Major Phytochemicals: Recent Advances in Health Benefits and Extraction Method · Ashwani Kumar · 2023 · 766 citations · Cited by this paper
  16. Hematopoietic and T-lymphopoiesis-stimulating effects of a fluorinated pyrazolopiperidine β-cyclodextrin complex in cyclophosphamide-induced hematopoietic suppression · 2026 · Related
  17. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease · Reenam S. Khan · 2018 · 549 citations · Cited by this paper
  18. Triple Agonism Based Therapies for Obesity · 2025 · Related
  19. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics · Xiaojun Feng · 2019 · 463 citations · Cited by this paper
  20. Different types of sweetened coffee consumption, genetic predictor of gut microbe, and the risk of metabolic dysfunction-associated steatotic liver disease · 2026 · Related
  21. Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease · Yamei Duan · 2022 · 364 citations · Cited by this paper
  22. Steatotic liver disease · Mads Egerod Israelsen · 2024 · 350 citations · Cited by this paper
  23. Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver · Erika Ramos‐Tovar · 2020 · 341 citations · Cited by this paper
  24. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes · Veeral H. Ajmera · 2022 · 317 citations · Cited by this paper
  25. Beneficial Effects of Betaine: A Comprehensive Review · Madan Kumar Arumugam · 2021 · 296 citations · Cited by this paper
  26. Role of the Inflammasome in Liver Disease · Marcelle de Carvalho Ribeiro · 2021 · 279 citations · Cited by this paper
  27. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD) · Raquel Benedé‐Ubieto · 2024 · 229 citations · Cited by this paper
  28. Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults · Herbert Tilg · 2025 · 197 citations · Cited by this paper
  29. Host-microbiome interactions: Gut-Liver axis and its connection with other organs · Swadha Anand · 2022 · 188 citations · Cited by this paper
  30. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism · Claudia O. Zein · 2012 · 163 citations · Cited by this paper
  31. Nuciferine protects against folic acid‐induced acute kidney injury by inhibiting ferroptosis · Danyu Li · 2021 · 162 citations · Cited by this paper
  32. Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family · Jingjing Du · 2021 · 152 citations · Cited by this paper
  33. Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease · Oveis Jamialahmadi · 2021 · 151 citations · Cited by this paper
  34. Sublethal necroptosis signaling promotes inflammation and liver cancer · Mihael Vucur · 2023 · 146 citations · Cited by this paper
  35. Betaine as a Functional Ingredient: Metabolism, Health-Promoting Attributes, Food Sources, Applications and Analysis Methods · Dejan Dobrijević · 2023 · 133 citations · Cited by this paper
  36. Machine learning enables new insights into genetic contributions to liver fat accumulation · Mary Elizabeth De Haas · 2021 · 111 citations · Cited by this paper
  37. The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver · Ingmar Mederacke · 2022 · 103 citations · Cited by this paper
  38. Rare ATG7 genetic variants predispose patients to severe fatty liver disease · Guido Baselli · 2022 · 97 citations · Cited by this paper
  39. Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach · Qi Quan · 2016 · 89 citations · Cited by this paper

Source: OpenAlex (CC0)